Lupin Limited has informed the Exchange regarding a press release dated January 16, 2023, titled "Lupin Receives Tentative Approval from U.S. FDA for Dolutegravir and RilpivirineTablets.".
Press Release Jan 16 2023
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Lupin
- Press Release Jan 10 2023
- Press Release Jan 09 2023
- Press Release Jan 06 2023
- Press Release Jan 05 2023
- Press Release Dec 22 2022
Later from Lupin
- Press Release Jan 18 2023
- Press Release Jan 24 2023
- Press Release Jan 31 2023
- Press Release Feb 03 2023
- Lupin Limited Press Release Feb 09 2023
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin